To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge

Summary

The purpose of the study is to determine whether Al38583 Ophthalmic Solution is safe and effective in reducing tear eosinophil levels at 5-8 hours after Conjunctival Allergen Challenge (CAC).

Timeline

Start

2009-05

Primary completion

2009-05

Completion

2009-05

Outcome

Outcome not reported

Stopped: “Management decision”

Drugs

Indications